Mylan sells its 5.64% Biocon stake within six months, institutional...
Mumbai: US-based generic pharma major Mylan has sold its 5.64% share in Biocon Ltd within 6 months of getting it. The shares were allocated to it as part of an...
Mumbai: US-based generic pharma major Mylan has sold its 5.64% share in Biocon Ltd within 6 months of getting it. The shares were allocated to it as part of an...